Acute Kidney Injury Clinical Trial
Official title:
An Ultrasound- Guided Algorithm for the Management of Oliguria in Septic Shock
Acute Kidney Injury (AKI) develops in 88% to 30% of critically ill patients admitted to an intensive care unit and is a strong predictor of mortality.Therefore any management strategy that prevents progression of renal risk to injury or failure has the potential to improve outcomes in these patients.Conventional management of acute oliguria in shock has been to blindly 'push' fluids to improve renal perfusion or to give loop diuretics once fluid loading has been considered as accomplished. However both volume overload and 'blind' attempts at fluid removal can worsen renal injury and have been associated with higher mortality by venous overcongestion and inappropriate hypovolemia. It seems reasonable to assume that a bedside test to visualize volume status and renal perfusion may assist in improving outcomes in this cohort.The investigators developed a goal-directed ultrasonographic protocol to provide immediate hemodynamic information in acutely oliguric patients with shock as well as a management algorithm for guiding therapy. The investigators incorporated IVC diameter measurement, respiratory variation and response to a passive leg raise to assess whether further fluid boluses were required and a measurement of renal perfusion to determine whether diuretics or renal replacement therapy were indicated. The investigators aim to measure the effects of this management protocol on the rates of AKI in the study participants as compared to prior to the implementation of the protocol.The study design is a prospective, observational. Since this is a proof of concept study, the projected sample size is 40 patients. An interim analysis will be carried out after 20 patients are enrolled and a further 20 will be enrolled as necessary
BACKGROUND & INTRODUCTION:
Acute Kidney Injury (AKI) develops in 88% to 30% of critically ill patients admitted to an
intensive care unit. While AKI of any severity is a strong predictor of mortality (1-4),
both morbidity and mortality increase with increasing severity of renal injury(2). Therefore
any management strategy that prevents progression of renal risk to injury or failure has the
potential to improve outcomes in these patients.
Conventional management of acute oliguria in shock has been to blindly 'push' fluids to
improve renal perfusion or to give loop diuretics once fluid loading has been considered as
accomplished. However both volume overload and 'blind' attempts at fluid removal can worsen
renal injury and have been associated with higher mortality by venous overcongestion (5) and
inappropriate hypovolemia (6-8). It seems reasonable to assume that a bedside test to
visualize volume status and renal perfusion may assist in improving outcomes in this cohort.
Intensive care unit (ICU) bedside ultrasound has become the standard of care for critically
ill patients(9-18). In patients with shock, inferior vena cava ultrasonographic evaluation
for 'fluid responsiveness' is routinely used to direct resuscitation (19-21) by direct
measurement of IVC diameter and respiratory variation or by the response to a noninvasive
fluid bolus from a passive leg raise (22). Doppler ultrasound of intrarenal vessels has also
been described as a tool to assess renal perfusion (23-27).
The investigators developed a goal-directed ultrasonographic protocol to provide immediate
hemodynamic information in acutely oliguric patients with shock as well as a management
algorithm for guiding therapy. The investigators incorporated IVC diameter measurement,
respiratory variation and response to a passive leg raise to assess whether further fluid
boluses were required and a measurement of renal perfusion to determine whether diuretics or
renal replacement therapy were indicated.
The objectives are to measure the effects of this management protocol on the rates of AKI in
the study participants as compared to prior to the implementation of the protocol.
METHODS:
1. Study Design: Prospective, Observational 2. Study Patients:
- Inclusion criteria: Critically ill, adult patients AND with acute oliguric renal
failure AND within 6 hours of presentation
- Exclusion criteria:
i. Patients with pre-existing chronic renal failure ii. Patients on renal replacement
therapy/ Dialysis iii. Patients with poor sonographic windows
3. Variables to be measured:
- Dependent variables:
a. Demographic identifiers; age, gender, comorbidity, admitting diagnosis, APACHE II
scores, b. Renal perfusion as measured by color Doppler c. Daily fluid balance, d. Mean
hourly urine output, e. Vasopressor use, f. Daily serum Creatinine g. Response to
diuretics h. Dose of diuretic that resulted in urine output
- Outcome variables:
1. Incidence of renal failure (classified into RIFLE categories; Risk, Injury,
Failure, Loss of Function, End-Stage: see Appendix 1),
2. ICU length of Stay,
3. ICU mortality
Materials & Methodologies:
1. Screening & Enrollment of patients:
1. All ICU patients admitted to the ICU will be screened for enrollment.
2. Those meeting inclusion criteria will have their Demographic information entered
in Case Record Forms (Appendix 2: Sample CRF)
3. Ultrasound examinations will be carried out and results entered into the CRF.
o For patients found to be intravascularly dehydrated (those with > 2 cm IVC
diameter (IVCd) or >15% variation in IVCd or an increase of > 15% in IVCd with a
passive leg raise maneuver), the results will be communicated to the managing ICU
team for fluid resuscitation
- For patients found to be adequately hydrated, renal perfusion will be
assessed by observing flow in the interlobar and arcuate vessels by colour
Doppler and the renal resistive index will be measured.
- The results of no perfusion or perfusion present will be communicated to the
managing ICU team for recommendation of high dose diuresis
2. Ultrasonographic assessment of Inferior Vena Cava Measurement of the inferior vena cava
diameter, and respiratory variation by ultrasound
(http://www.criticalecho.com/content/tutorial-4-volume-status-and-preload-responsiveness-assessment) Ultrasonographic assessment of the IVC will be done using a transthoracic, subcostal approach. The transducer will be positioned just below the xiphisternum 1-2cms to the right of the midline, with the marker dot pointing towards the sternal notch. After obtaining a 2-D image of the IVC entering the right atrium and verifying that the IVC visualization is not lost during movements of respiration, an M-mode line will be placed through the IVC 1 cm caudal from its junction with the hepatic vein, and an M-mode tracing obtained. This placement ensures that the intrathoracic IVC is not measured during any part of the respiratory cycle. The M-mode tracing will be recorded through 3- 4 respiratory cycles, the image frozen and using calipers, the maximum and minimum diameters of the IVC tracing measured. IVC variation will be quantified by measuring the difference between the maximum and minimum diameters on the M-mode tracing.
Ultrasonographic assessment of Renal Perfusion by color Doppler
Vessel localization and a semi-quantitative evaluation of renal perfusion will be
carried out using the following staging method.
(http://link.springer.com/chapter/10.1007%2F978-3-642-10286-8_31 - page-1)
Stage Quality of Renal Perfusion by color Doppler 0 Unidentifiable vessels 1 Few
vessels in vicinity of hilum 2 Hilar and intralobar vessels in most of renal parenchyma
3 Renal vessels identifiable until the arcuate arteries in the entire field of view
3. Statistical Methods:
1. Sample size & Sampling: Consecutive admissions to the ICU will be enrolled. Since
this is a proof of concept study, the projected sample size is 40 patients. An
interim analysis will be carried out after 20 patients are enrolled and a further
20 will be enrolled as necessary
2. Analysis: Categorical variables will be reported as proportions or percentages,
continuous variables as means or medians. Differences between groups will be
estimated using CHI2, student t test or Mann-Whitney U test, as appropriate. Rates
of renal injury from historical controls will be compared to rates measured using
t test for paired samples. A p value =0.05 will be considered significant. SPSS
version 22.0 will be used for all analysis.
ETHICAL CONSIDERATIONS:
1. Informed Consent for ultrasonographic examination. The use of use of ultrasound for the
assessment and management of critically ill patients in the ICU and emergency room is
considered as standard of care and is routinely practiced in ICUs around the world.
Since ultrasound evaluation has become incorporated into usual ICU practice, written
consent is not required in its routine use. We therefore ask for a waiver of informed
consent since we will not be performing any deviation from usual ICU care and our study
is simply a collection of practice into a protocolized form.
(Please see References 9-27)
2. Research Advisory Committee (RAC) Review This protocol will be reviewed and approved by
the hospital Research Advisory committee responsible for oversight of the study.
2. Subject Confidentiality & Protection of Rights of Control Subjects All case record forms,
reports and other records will be identified only by the Study Identification Number (SID)
to maintain subject confidentiality. All records will be kept in a password-protected file.
All computer entry and networking programs will be done using SIDs only.
3. Study Modification/Discontinuation The study may be modified or discontinued at any time
by the primary investigators and or Research Advisory Committee as part of their duties to
ensure that research subjects are protected.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05538351 -
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03938038 -
Guidance of Ultrasound in Intensive Care to Direct Euvolemia
|
N/A | |
Recruiting |
NCT05805709 -
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
|
N/A | |
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
Recruiting |
NCT05897840 -
Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04986137 -
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
|
||
Terminated |
NCT04293744 -
Acute Kidney Injury After Cardiac Surgery
|
N/A | |
Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
Not yet recruiting |
NCT06026592 -
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
|
||
Not yet recruiting |
NCT06064305 -
Transcriptional and Proteomic Analysis of Acute Kidney Injury
|
||
Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
Terminated |
NCT03305549 -
Recovery After Dialysis-Requiring Acute Kidney Injury
|
N/A | |
Completed |
NCT05990660 -
Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
Terminated |
NCT02860130 -
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
|
Phase 3 | |
Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
Not yet recruiting |
NCT05548725 -
Relation Between Acute Kidney Injury and Mineral Bone Disease
|
||
Completed |
NCT02665377 -
Prevention of Akute Kidney Injury, Hearttransplant, ANP
|
Phase 3 | |
Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A |